These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18976206)

  • 1. Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
    Dossou AD; Sopoh GE; Johnson CR; Barogui YT; Affolabi D; Anagonou SY; Zohoun T; Portaels F; Asiedu K
    Med J Aust; 2008 Nov; 189(9):532-3. PubMed ID: 18976206
    [No Abstract]   [Full Text] [Related]  

  • 2. The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series.
    Jerjen R; Moodley A; Sinclair R
    Australas J Dermatol; 2020 Nov; 61(4):376-377. PubMed ID: 32578188
    [No Abstract]   [Full Text] [Related]  

  • 3. Buruli ulcer accompanied by pain in a Japanese patient.
    Onoe H; Yotsu RR; Nakanaga K; Hoshino Y; Ishii N; Takeuchi T
    J Dermatol; 2012 Oct; 39(10):869-70. PubMed ID: 22168180
    [No Abstract]   [Full Text] [Related]  

  • 4. Buruli ulcer in an 18-day-old baby.
    Kiiza AM; Wood PB
    Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To Buruli or not to Buruli.
    Ho L; Cohn J; Comte E
    Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682
    [No Abstract]   [Full Text] [Related]  

  • 6. Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire.
    Yotsu RR; Murase C; N'guessan K; Yao A; Kouadio K; N'Golo DC; N'Guetta A; Akiyama M; Constance K; Vagamon B
    J Dermatol; 2020 Feb; 47(2):e64-e65. PubMed ID: 31729074
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
    Cowan R; Athan E; Friedman ND; Hughes AJ; McDonald A; Callan P; Fyfe J; O'Brien DP
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003503. PubMed ID: 25658304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
    Chauty A; Ardant MF; Marsollier L; Pluschke G; Landier J; Adeye A; Goundoté A; Cottin J; Ladikpo T; Ruf T; Ji B
    Clin Infect Dis; 2011 Jan; 52(1):94-6. PubMed ID: 21148526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
    Amoako YA; Frimpong M; Awuah DO; Plange-Rhule G; Boakye-Yiadom E; Agbavor B; Sarpong F; Ahor H; Adu E; Danso KG; Abass MK; Asiedu K; Wansbrough-Jones M; Phillips RO
    J Med Case Rep; 2019 Jul; 13(1):218. PubMed ID: 31315637
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chamseddine S; Hindy JR; Haddad SF; Kanj SS
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35944937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
    Warryn L; Pluschke G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0087021. PubMed ID: 34662181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient.
    Ashok A; Warner VM; Gardiner BJ
    Transpl Infect Dis; 2024 Jun; 26(3):e14262. PubMed ID: 38430479
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious disease. Elusive pathogen cornered at last.
    Youngsteadt E
    Science; 2008 Mar; 319(5871):1747. PubMed ID: 18369112
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
    Phillips RO; Sarfo FS; Abass MK; Abotsi J; Wilson T; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014; 58(2):1161-6. PubMed ID: 24323473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense".
    Watanabe T; Ohkusu K; Nakanaga K; Ishii N; Nakashima K; Shindo M; Yoshida Y; Yamamoto O
    Eur J Dermatol; 2010; 20(6):809-10. PubMed ID: 20822972
    [No Abstract]   [Full Text] [Related]  

  • 19. Compliance with antimicrobial therapy for buruli ulcer.
    Klis S; Kingma R; Tuah W; Stienstra Y; van der Werf TS
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6340. PubMed ID: 25225342
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to "compliance with antimicrobial therapy for buruli ulcer".
    Phillips RO; Sarfo FS; Abass MK; Frimpong M; Ampadu E; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6341. PubMed ID: 25225343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.